슈퍼버그: Vancomycin-Resistant Enterococcus와 Carbapenem 내성균

키워드

참고문헌 (40)

1. Hawkey PM, "The changing epidemiology of resistance", J Antimicrob Chemother, 64, pp.3~10 (2009)
2. Petrosillo N, "Management of antibiotic resistance in the intensive care unit setting", Expert Rev Anti Infect, 8(3), pp.289~302 (2010)
3. Klugman KP, "The successful clone: the vector of dissemination of resistance in streptococcus pneumoniae", J Antimicrob Chemother, 50(Suppl S2), pp.1~5 (2002)
4. Albrich WC, "Antibiotic selection pressure and resistance in streptococcus pneumoniae and streptococcus pyogenes", Emerg Infect Dis, 10(3), pp.514~517 (2004)
5. Pillar C, "Resistance trends and susceptibility profiles in the US among prevalent clinical pathogens: lessons from surveillance", Antibiotic Discovery and Development, pp753~pp792 (2012)
6. Kehrenberg C, "Methicillin-resistant and -susceptible staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr", Antimicrob Agents Chemother, 53, pp.779~781 (2009)
7. Garcia-Fernandez A, "Multilocus sequence typing of IncI1 plasmids carrying extendedspectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin", J Antimicrob Chemother, 61(6), pp.1229~1233 (2008)
8. Boucher HW, "Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of america", Clin Infect Dis, 48(1), pp.1~12 (2009)
9. Mulvey MR, "Antimicrobial resistance in hospitals: how concerned should we be?", CMAJ, 180(4), pp.408~415 (2009)
10. Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006-2007", Infect Control Hosp Epidemiol, 29(11), pp.996~1011 (2008)
11. Brown DF, "Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06", J Antimicrob Chemother, 62(Suppl 2), pp.ii75~ii85 (2008)
12. Walsh FM, "Microbiology and drug resistance mechanisms of fully resistant pathogens", Curr Opin Microbiol, 7(5), pp.439~444 (2004)
13. Werner G, "Emergence and spread of vancomycin resistance among enterococci in Europe", Euro Surveill, 13(47), pp.pii19046~ (2008)
14. Arias CA, "Management of multidrug-resistant enterococcal infections", Clin Microbiol Infect, 16(6), pp.555~562 (2010)
15. Toh SM, "Acquisition of a natural resistance gene renders a clinical strain of methicillin- resistant staphylococcus aureus resistant to the synthetic antibiotic linezolid", Mol Microbiol, 64(6), pp.1506~1514 (2007)
16. Arias CA, "Clinical and microbiological aspectsof linezolid resistance mediated by the cfr gene encoding a 23S Rrna methyltransferase", J Clin Microbiol, 46(3), pp.892~896 (2008)
17. Birmingham MC, "Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program", Clin Infect Dis, 36(2), pp.159~168 (2003)
18. Enoch DA, "Daptomycin", J Infect, 55(3), pp.205~213 (2007)
19. Silverman JA, "Correlation of daptomycin bactericidal activity and membrane depolarization in staphylococcus aureus", Antimicrob Agents Chemother, 47(8), pp.2538~2544 (2003)
20. Slover CM, "Tigecycline: a novel broad-spectrum antimicrobial", Ann Pharmacother, 41(6), pp.965~972 (2007)
21. Werner G, "Tigecycline-resistant enterococcus faecalis strain isolated from a german intensive care unit patient", J Antimicrob Chemother, 61(5), pp.1182~1183 (2008)
22. Ellis-Grosse EJ, "The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam", Clin Infect Dis, 5, pp.S341~S353 (2005)
23. Arias CA, "Emergence and management of drug-resistant enterococcal infections", Expert Rev Anti Infect Ther, 6(5), pp.637~655 (2008)
24. Chow JW, "Aminoglycoside resistance in enterococci", Clin Infect Dis, 31(2), pp.586~589 (2000)
25. Miriagou V, "Acquired carbapenemases in gram-negative bacterial pathogens: detection and surveillance issues", Clin Microbiol Infect, 16(2), pp.112~122 (2010)
26. Nordmann P, "Rapid detection of carbapenemase-producing enterobacteriaceae", Emerg Infect Dis, 18(9), pp.1503~1507 (2012)
27. Gasink LB, "Risk factors and clinical Impact of klebsiella pneumoniae carbapenemase- producing k. pneumonia", Infect Control Hosp Epidemiol, 30(12), pp.1180~1185 (2009)
28. 이경원, "2006년 서울과 경기지역 4개 병원에서 분리된 Carbapenem 내성 Acinetobacter spp.의 내성 기전과 분자역학", Annals of Clinical Microbiology, 13(1), pp.27~33 (2010), 대한임상미생물학회
29. Yigit H, "Novel carbapenem hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of klebsiella pneumoniae", Antimicrob Agents Chemother, 45(4), pp.1151~1161 (2001)
30. Bradford PA, "Emergence of carbapenem-resistant klebsiella species possessing the class a carbapenem- hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in new york city", Clin Infect Dis, 39(1), pp.55~60 (2004)
31. Rasheed JK, "Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem- hydrolyzing enzyme in clinical isolates of citrobacter freundii and K. oxytoca carrying a common plasmid", J Clin Microbiol, 46(6), pp.2066~2069 (2008)
32. Deshpande LM, "Emergence of serine carbapenemases (KPC and SME) among clinical strains of enterobacteriaceae isolated in the united states medical centers: report from the MYSTIC program (1999-2005)", Diagn Microbiol Infect Dis, 56(4), pp.367~372 (2006)
33. Navon-Venezia S, "First report on a hyperepidemic clone of KPC-3-producing klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States", Antimicrob Agents Chemother, 53(2), pp.818~820 (2009)
34. Mendes RE, "Carbapenem-resistant isolates of klebsiella pneumoniae in china and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene", Antimicrob Agents Chemother, 52(2), pp.798~799 (2008)
35. Carmeli Y, "Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control", Clin Microbiol Infect, 16(2), pp.102~111 (2010)
36. Bulik CC, "Double-Carbapenem Therapy for carbapenemase-producing klebsiella pneumoniae", Antimicrob Agents Chemother, 55(6), pp.3002~3004 (2011)
37. Ku K, "Retrospective evaluation of colistin versus tigecycline for the treatment of acinetobacter baumannii and", or carbapenem-resistant enterobacteriaceae infections, 2012, 1~5
38. Peck KR, "In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem- resistant acinetobacter baumannii, including colistin- or tigecycline-resistant isolates", J Med Microbiol, 61(Pt3), pp.353~360 (2012)
39. Warren RE, "Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK", J Antimicrob Chemother, 61(3), pp.504~508 (2008)
40. Nordmann P, "The real threat of klebsiella pneumoniae carbapenemase-producing bacteria", Lancet Infect Dis, 9(4), pp.228~236 (2009)

관련 논문AI추천